Endothelial Function in Obstructive Sleep Apnea and Response to Treatment

American Journal of Respiratory and Critical Care Medicine

Volumn 169, Issue 3, 2004, Pages 348-353

  Ip, Mary S M ^a   Tse, Hung Fat ^a   Lam, Bing ^a   Tsang, Kenneth W T ^a   Lam, Wan Kit ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Endothelial function; Flow mediated dilation; Nasal continuous positive airway pressure; Obstructive sleep apnea; Vascular reactivity

Indexed keywords

GLYCERYL TRINITRATE;

ADULT; AGE; ARTERY DILATATION; ARTICLE; BLOOD FLOW; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DOPPLER ECHOGRAPHY; ENDOTHELIUM; HOSPITALIZATION; HUMAN; LARYNGEAL MASK; MALE; MULTIVARIATE ANALYSIS; OBSERVATION; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROBABILITY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SLEEP APNEA SYNDROME; STATISTICAL MODEL; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

EID: 1642578214     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200306-767oc     Document Type: Article

References (51)

1. Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001;164:2147-2165.
2. Peppard PE, Young T, Palta M, Skaturd J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-1384.
3. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea. Am J Respir Crit Care Med 2002;166:159-165.
4. Hedner JA, Wilcox I, Sullivan CE. Speculations on the interaction between vascular disease and obstructive sleep apnea. In: Saunders NA, Sullivan CE, editors. Sleep and breathing. New York: Marcell Dekker; 1994. pp. 823-846.
5. Dean RT, Wilcox I. Possible atherogenic effects of hypoxia during obstructive sleep apnea. Sleep 1993;16:S15-S22.
6. Shepard JW Jr. Gas exchange and hemodynamics during sleep. Med Clin North Am 1985;69:1243-1264.
7. Zwillich C, Sinoway L. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 1995;79: 581-588.
8. Somers VK, Kyken ME, Clary MP, Abbound FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897-1904.
9. Xie A, Skatrud JB, Brabtree DC, Puleo DS, Goodman BM, Morgan BJ. Neurocirculatory consequences of intermittent asphyxia in humans. J Appl Physiol 2000;89:1333-1339.
10. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 2003;7:35-51.
11. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.
12. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 1999;31:23-27.
13. Neunteuff T, Heher S, Katzenschlager R, Wolfl G, Kostner K, Maurer G, Weidinger F. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 2000; S6:207-210.
14. Vogel RA. Heads and hearts: the endothelial connection. Circulation 2003;107:2766-2768.
15. Carlson JT, Rangemark C, Hedner JA. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 1996;14:577-584.
16. Kato M, Roberts-Thomson P, Phillips BG, Hayes WG, Winnicki M, Accurso V, Somers VK. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000;102:2607-2610.
17. Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 2001;119:1085-1091.
18. Duchna HW, Guilleminault C, Stoohs RA, Faul JL, Moreno H, Hoffman BB, Blaschke TF. Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2000;161:187-191.
19. Ip MSM, Lam B, Chan LY, Zheng L, Tsang KWT, Fung PCW, Lam WK. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162:2166-2171.
20. Rechtschaffen A, Kales AA, editors. A manual of standardized terminology, techniques and scoring for sleep stages of human subjects. Washington, DC: Government Printing Office; 1968. NIH Publication No. 204.
21. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667-89.
22. American Sleep Disorders Association. EEG arousals: scoring rules and examples. Sleep 1992;15:175-184.
23. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
24. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea. Am J Respir Crit Care Med 2002;154:1217-1239.
25. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 1997;30:325-333.
26. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994;23:833-843.
27. Anderson TJ. Assessment and treatment of endothelial dysfunction in human. J Am Coll Cardiol 1999;34:631-638.
28. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002;165:934-939.
29. Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H, Ouchi Y. Increased levels of circulating ICAM-1, VCAM-1, and L-selection in obstructive sleep apnea syndrome. J Appl Physiol 1999; 87:10-14.
30. Wessendorf TE, Thilmann AF, Wang YM, Wang YM, Schreiber A, Konietzko N, Teschler H. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 2000;162:2039-2042.
31. Rangemark C, Hedner JA, Carlson JT, Gleerup G, Winther K. Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. Sleep 1995;18:188-194.
32. Kraiczi H, Hedner J, Peker Y, Carlson J. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 2000;89:493-498.
33. Imadojemu VA, Gleeson K, Quraishi SA, Kunselman AR, Sinoway LI, Leuenberger UA. Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. Am J Respir Crit Care Med 2002;165:950-953.
34. Engelke KA, Halliwill HR, Proctor DN, Dietz NM, Joyner MJ. Contribution of nitric oxide and prostaglandins to reactive hyperemia in the human forearm. J Appl Physiol 1996;81:1807-1814.
35. Schubert R, Mulvany MJ. The myogenic response: established facts and attractive hypotheses. Clin Sci 1999;96:313-326.
36. Joyner MJ, Dietz NM. Nitric oxide and vasodilation in human limbs. J Appl Physiol 1997;83:1785-1796.
37. Raitakari OT, Celermajer DS. Flow-mediated dilatation. Br J Clin Pharmacol 2000;50:397-404.
38. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Herman MG, Herrington D, et al. Guidelines for the ultrasound assessment of endothelium-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 2002;39:257-265.
39. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Luscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-1319.
40. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, Deanfield JE. Noninvasive measurement of human endothelium- dependent arterial responses: accuracy and reproducibility. Br Heart J 1995;74:247-253.
41. Anderson TJ, Uchata A, Gerhard MD, Meredith IT, Knab S, Delagrance D, Lieberman EH, Ganz P, Creager MA, Yeung AC, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235-1241.
42. Takase B, Uehata A, Akima Ta, Nagai T, Nishiioka T, Hamabe A, Satomura K, Ohsuzu F, Jurita A. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol 1998;82:1535-1539.
43. Arcaro G, Zamboni M, Rossi L, Turcato E, Covi G, Armellini F, Bosello O, Lechi A. Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord 1999;23:936-942.
44. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJO. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359:204-210.
45. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354:1435-1439.
46. Busse R, Fleming I. Regulation and functional consequences of endothelial nitric oxide formation. Ann Med 1995;27:331-340.
47. Hijmering ML, Stores ESG, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ. Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation. J Am Coll Cardiol 2002;39: 683-688.
48. Schulz R, Mahmoudi S, Hattar K, Sibelius ULF, Olschewski H, Mayer K, Seeger W, Grimminger F. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000;162:566-570.
49. Ip MS, Lam B, Ng MM, Lam WK, Tsang KWT, Lam KSL. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002;165:670-676.
50. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002;40:505-510.
51. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.